BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19903426)

  • 1. Optimizing conventional therapies for inflammatory bowel disease.
    Sparrow MP; Irving PM; Hanauer SB
    Curr Gastroenterol Rep; 2009 Dec; 11(6):496-503. PubMed ID: 19903426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing conventional therapy for inflammatory bowel disease.
    Schwartz M; Cohen R
    Curr Gastroenterol Rep; 2008 Dec; 10(6):585-90. PubMed ID: 19006615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic agents in the treatment of inflammatory bowel disease.
    Geier DL; Miner PB
    Am J Med; 1992 Aug; 93(2):199-208. PubMed ID: 1497017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing the risks of IBD therapy.
    Seow CH; de Silva S; Kaplan GG; Devlin SM; Ghosh S; Panaccione R
    Curr Gastroenterol Rep; 2009 Dec; 11(6):509-17. PubMed ID: 19903428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium.
    Moffatt DC; Bernstein CN
    Best Pract Res Clin Gastroenterol; 2007; 21(5):835-47. PubMed ID: 17889811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and emerging drugs for the treatment of inflammatory bowel disease.
    Triantafillidis JK; Merikas E; Georgopoulos F
    Drug Des Devel Ther; 2011 Apr; 5():185-210. PubMed ID: 21552489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical therapy of IBD in 2009.
    Harris A; Feller ER; Shah SA
    Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolving treatment strategies for inflammatory bowel disease.
    Hanauer SB; Dassopoulos T
    Annu Rev Med; 2001; 52():299-318. PubMed ID: 11160781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Therapy for Inflammatory Bowel Disease.
    Grevenitis P; Thomas A; Lodhia N
    Surg Clin North Am; 2015 Dec; 95(6):1159-82, vi. PubMed ID: 26596920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing thiopurine therapy in inflammatory bowel disease.
    Chevaux JB; Peyrin-Biroulet L; Sparrow MP
    Inflamm Bowel Dis; 2011 Jun; 17(6):1428-35. PubMed ID: 20949566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
    Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
    Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events of IBD therapies.
    Scribano ML
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S210-1. PubMed ID: 18816669
    [No Abstract]   [Full Text] [Related]  

  • 13. Conventional drug therapy for inflammatory bowel disease.
    Bryant RV; Brain O; Travis SP
    Scand J Gastroenterol; 2015 Jan; 50(1):90-112. PubMed ID: 25523560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimising use of thiopurines in inflammatory bowel disease.
    Dart RJ; Irving PM
    Expert Rev Clin Immunol; 2017 Sep; 13(9):877-888. PubMed ID: 28678626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?
    van Bodegraven AA; Mulder CJ
    World J Gastroenterol; 2006 Oct; 12(38):6115-23. PubMed ID: 17036381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD.
    Amin J; Huang B; Yoon J; Shih DQ
    Inflamm Bowel Dis; 2015 Feb; 21(2):445-52. PubMed ID: 25248004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of biologic agents in pediatric inflammatory bowel disease.
    Rosh JR
    Curr Opin Pediatr; 2009 Oct; 21(5):646-50. PubMed ID: 19629010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α.
    Park J; Cheon JH
    Korean J Intern Med; 2022 Sep; 37(5):895-905. PubMed ID: 35882566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease and the elderly: a review.
    Taleban S; Colombel JF; Mohler MJ; Fain MJ
    J Crohns Colitis; 2015 Jun; 9(6):507-15. PubMed ID: 25870198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of IBD: where we are and where we are going.
    Bernstein CN
    Am J Gastroenterol; 2015 Jan; 110(1):114-26. PubMed ID: 25488896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.